How can Cost Effectiveness Analysis be Made More Relevant to U.S. Health Care?
Wei Yu, PhD
Seminar date: 4/25/2018
Description: After providing a brief reminder of the elements of a cost-effectiveness analysis, this lecture will describe how health policy decisions in other countries use it to set practice guidelines, determine pharmacy formularies, and make coverage decisions. Attempts to formally incorporate cost-effectiveness into U.S. policy have failed, but there are many examples of informal use of cost-effectiveness findings. Surveys of decision makers have identified barriers to using cost-effectiveness findings to make health care decisions. Published recommendations provide economics researchers with tips on how to increase the chances that their findings will be implemented.